TWM597140U - Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate - Google Patents

Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate Download PDF

Info

Publication number
TWM597140U
TWM597140U TW109202035U TW109202035U TWM597140U TW M597140 U TWM597140 U TW M597140U TW 109202035 U TW109202035 U TW 109202035U TW 109202035 U TW109202035 U TW 109202035U TW M597140 U TWM597140 U TW M597140U
Authority
TW
Taiwan
Prior art keywords
polysaccharide
huangqi
particles
crystal
patent application
Prior art date
Application number
TW109202035U
Other languages
Chinese (zh)
Inventor
李伊伶
鄭傑方
Original Assignee
懷特生技新藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 懷特生技新藥股份有限公司 filed Critical 懷特生技新藥股份有限公司
Priority to TW109202035U priority Critical patent/TWM597140U/en
Priority to JP2020001395U priority patent/JP3228581U/en
Publication of TWM597140U publication Critical patent/TWM597140U/en

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本創作提供一種提升溶解力與吸收率之黃耆多醣晶體顆粒結構,包含黃耆多醣顆粒和甘露糖顆粒藉由水鏈結構鏈結在一起,使黃耆多醣顆粒會分散於水蒸氣中,分散的黃耆多醣顆粒結構和水蒸氣形成小顆粒,該小顆粒較大顆粒有更大的體表面積,且黃耆多醣晶體顆粒結構不含有膠體成分,因此可以提升食用後在體內的溶解力與吸收率,提升產品功效。 This creation provides a crystal structure of Huangqi polysaccharide crystals that enhances the dissolution and absorption rate. It contains Huangqi polysaccharide particles and mannose particles linked together by a water chain structure, so that Huangqi polysaccharide particles will be dispersed in water vapor and dispersed. The granule structure of Huangqi polysaccharide and water vapor form small particles, the larger particles have larger body surface area, and the crystal structure of Huangqi polysaccharide crystal does not contain colloidal components, so it can improve the dissolution and absorption in the body after eating Rate, improve product efficacy.

Description

具提升溶解力與吸收率之黃耆多醣晶體顆粒結構 The crystal structure of Huangqi polysaccharide crystals with enhanced dissolving power and absorption rate

本創作提供一種提升溶解力與吸收率之黃耆多醣晶體顆粒結構,包含黃耆多醣顆粒和甘露糖顆粒藉由水鏈結構鏈結在一起,使黃耆多醣晶體顆粒會均勻的分散於溶液中,均勻分散的黃耆多醣晶體顆粒結構小顆粒較大顆粒有更大的體表面積,提升食用後在體內的溶解力與吸收率,提升產品功效。 This creation provides a structure of Huangqi polysaccharide crystal particles that enhances the dissolution and absorption rate. It contains Huangqi polysaccharide particles and mannose particles linked together by a water chain structure, so that Huangqi polysaccharide crystal particles will be uniformly dispersed in the solution. , Evenly dispersed Astragalus polysaccharide crystal particle structure, small particles, larger particles have a larger body surface area, improve the dissolution and absorption rate in the body after consumption, and improve product efficacy.

根據多篇醫學的報導「癌症可能是一種新陳代謝疾病」,因此,長期的壓力會產生大量的「細胞激素」,這種發炎性蛋白會增加發炎的可能性,從而損害免疫功能,促進癌細胞生長。美國國家科學期刊報導一項研究,解開癌細胞的代謝機制,證實癌細胞是正常細胞新陳代謝途徑產生變異造成。 According to several medical reports "cancer may be a metabolic disease", long-term stress will produce a large amount of "cytokines", this inflammatory protein will increase the possibility of inflammation, thereby impairing immune function and promoting cancer cell growth . The National Science Journal reported a study that unravels the metabolic mechanism of cancer cells and confirms that cancer cells are caused by mutations in normal cell metabolism pathways.

在細胞代謝過程中,食物進入人體會轉換成葡萄糖,正常的細胞在分解葡萄糖之後,會產生「丙酮酸」,進入粒線體(生物能量工廠)產生細胞所需的能量,讓細胞正常運作。但癌細胞的代謝途徑,卻是僅有少量的丙酮酸會進入粒線體,大部分丙酮酸則是產生大量乳酸,進而促成腫瘤生長。 In the process of cell metabolism, food enters the body and is converted into glucose. After normal cells decompose glucose, they produce "pyruvate" and enter the mitochondria (bioenergy factories) to produce the energy needed by the cells and allow the cells to function normally. But the metabolic pathway of cancer cells is that only a small amount of pyruvate enters the mitochondria, and most pyruvate produces a large amount of lactic acid, which in turn promotes tumor growth.

其中,PMK2酵素如「守門人」,大部分葡萄糖經PMK2會轉化為能量與二氧化碳,但當致癌因子JMJD5出現後,PMK2與JMJD5 結合,就會使PMK2酵素去守門功能。研究人員表示,癌症病患治療中早有限制糖分攝取的飲食指引,目前部分控制糖尿病血糖的藥,也證實能抑制腫瘤生長,說明新陳代謝正常運作與癌症防治的確是有關係。 Among them, PMK2 enzymes such as "gatekeepers", most of the glucose will be converted into energy and carbon dioxide by PMK2, but when the oncogenic factor JMJD5 appears, PMK2 and JMJD5 The combination will make the PMK2 enzyme go to the gatekeeping function. Researchers say that there are dietary guidelines that restrict sugar intake early in the treatment of cancer patients. Some drugs that control diabetes and blood sugar have also been shown to inhibit tumor growth, indicating that the normal operation of metabolism is indeed related to cancer prevention.

目前的癌症藥物,多半以阻斷癌細胞的生長,或是破壞癌細胞的基因及生長機制,但這些做法往往傷害了正常細胞。 Current cancer drugs mostly block the growth of cancer cells or destroy the genes and growth mechanisms of cancer cells, but these practices often harm normal cells.

黃耆在中藥裡被歸類為補氣的上藥,有研究指出黃耆對於新陳代謝路徑具有正常化的功效,透過正常化癌化細胞的新陳代謝路徑,便能有機會成功減緩癌細胞增生速度,而不會影響正常細胞,更不會有副作用產生。在諸多科學報導中指出,黃耆萃取物具有擴張血管,提高血氧,旺盛精神,降低血糖的功能,讓身體不會處於低溫、高糖,缺氧的狀態,細胞就會使用正常的粒腺體產能途徑(不使用無氧呼吸),就不會有大量的丙酮酸生成,使癌細胞無法使用丙酮酸來增生。具有降低體內乳酸產量的功能,進而可以降低癌細胞利用乳酸進行的增生。 Huang Qi is classified as a qi-invigorating medicine in Chinese medicine. Some studies indicate that Huang Qi has a normalizing effect on the metabolic pathway. By normalizing the metabolic pathway of cancerous cells, you can have the opportunity to successfully slow down the proliferation of cancer cells. It will not affect normal cells, nor will there be side effects. It has been pointed out in many scientific reports that the extract of Huangqi has the functions of dilating blood vessels, improving blood oxygen, energizing spirit, and lowering blood sugar, so that the body will not be in a state of low temperature, high sugar, and hypoxia, and the cells will use normal granules. The body energy pathway (without using anaerobic respiration), there will not be a lot of pyruvate production, so that cancer cells can not use pyruvate to proliferate. It has the function of reducing the production of lactic acid in the body, which can further reduce the proliferation of cancer cells using lactic acid.

在各種類黃耆中,產地在蒙古北部的膜莢黃耆,又稱為北耆,所含的黃耆多醣效果最佳,具有提升免疫、抗癌和抗老作用。 Among the various types of Astragalus membranaceus, the Astragalus membranaceus, which is produced in northern Mongolia, is also known as the North Astragalus. It contains the best Astragalus polysaccharides and has the effects of improving immunity, anti-cancer and anti-aging.

黃耆萃取物有提高超氧化物歧化酶活性、抗氧化物質,具有清除超氧陰離子自由基、羥自由基和多形核白血球呼吸爆發所生產的活性氧作用。可使細胞生理代謝作用增強,延長細胞的壽命的抗衰老作用。黃耆還有抗壓力的作用,包括抗疲勞的作用,耐低溫、高溫作用,抗輻射作用,抗缺氧作用。黃耆醇萃取液、黃耆皂甙能增強離體動物心臟的收縮力,黃耆多醣對心肌缺血有保護作用,並有抗心律失調作用、擴張血管、擴張冠狀動脈及降壓作用。 The extract of Huangqi can improve the activity of superoxide dismutase and anti-oxidation substances, and it can remove the active oxygen produced by superoxide anion free radical, hydroxyl free radical and polymorphonuclear leukocyte respiratory burst. Anti-aging effect that can enhance the physiological metabolism of cells and extend the life of cells. Huang Qi also has anti-stress effect, including anti-fatigue effect, low temperature and high temperature resistance, anti-radiation effect, anti-hypoxia effect. Astragalus alcohol extract and Astragalus saponin can enhance the contractility of the isolated animal heart. Astragalus polysaccharides have a protective effect on myocardial ischemia, and have anti-arrhythmic effects, dilation of blood vessels, dilation of coronary arteries and blood pressure.

由上所述可以知道黃耆萃取物作為保健食品對於癌症的預防具有相當的功效,雖然目前市面上都是黃耆飲片,較少黃耆萃取物,但是這些黃耆萃取物的保健食品其是否能有效的被人體吸收其實是有很大 的疑問,因為黃耆萃取物為潮濕粉體狀態,流動性極差,無法進行產品下料包裝的製程。且黃耆萃取物含高濃度的多醣體,但是因為多醣體具有易吸收濕氣,與高黏性高膠化的特性,經過一段時間,會黏著成一大塊不水溶的硬塊,不但影響產品的安全品質,更大大的降低產品在體內的吸收率。 It can be known from the above that Huangqi extract as a health food has a considerable effect on the prevention of cancer. Although currently there are Huangqi decoction pieces on the market, there are fewer Huangqi extracts, but are these health foods of Huangqi extract It can be effectively absorbed by the body Question, because the extract of Astragalus membranaceus is in the state of moist powder, and its fluidity is extremely poor, so it is impossible to carry out the process of product packaging. Moreover, the extract of Huangqi contains high concentration of polysaccharides, but because the polysaccharides have the characteristics of easy absorption of moisture, high viscosity and high gelation, after a period of time, they will stick to a large water-insoluble hard block, which not only affects the product Safe quality, greatly reduce the absorption rate of products in the body.

因此開發出適合的黃耆多醣晶體顆粒結構,讓黃耆萃取物在製造過程以及保存過程都能維持有穩定的結構,並且在進入人體內後能有效的被吸收達到減緩壓力、提高並預防癌症的功效,是現階段最重要急需解決的問題。 Therefore, a suitable crystal structure of Astragalus polysaccharides has been developed, so that the extracts of Astragalus membranaceus can maintain a stable structure during the manufacturing process and storage process, and can be effectively absorbed after entering the human body to reduce stress, improve and prevent cancer The efficacy of this is the most important problem that needs to be solved urgently at this stage.

除非另有定義,否則本文所使用的所有技術術語具有與本創作所屬領域中一般技術人員所知相同的含義。除非上下文另有明確指出,否則本說明書及隨附權利要求中所使用的單數形式「一個」、「一種」等包括複數提述。除非另有說明,否則本文中對「或」的任何提述旨在涵蓋「和/或」。 Unless otherwise defined, all technical terms used herein have the same meaning as those of ordinary skill in the art to which this creation belongs. Unless the context clearly indicates otherwise, the singular forms "a" and "an" used in this specification and the appended claims include plural references. Unless otherwise stated, any reference to "or" in this document is intended to cover "and/or".

以下將提供本創作一些層面的解說,該些解說係以一簡化的形式呈現本創作選定的概念,作為以下呈現的更加詳盡描述的介紹。 The following will provide an explanation of some aspects of the creation. These explanations present the selected concepts of the creation in a simplified form as an introduction to the more detailed description presented below.

為解決上述的問題,本創作開發出由一黃耆多醣顆粒和一甘露醣顆粒所結合的一種黃耆多醣晶體顆粒結構,並且透過水鏈結構讓黃耆萃取物在製造過程以及保存過程都能維持有穩定的結構。 In order to solve the above-mentioned problems, this creation developed a crystal structure of Huangqi polysaccharide crystals composed of a Huangqi polysaccharide particle and a mannose particle, and through the water chain structure, the Huangqi extract can be used in the manufacturing process and preservation process. Maintain a stable structure.

黃耆多醣晶體顆粒結構組成,進一步添加甘露糖作為結構的搭配成分,透過結構的設計解決黃耆與甘露醣均為極易吸濕的特性造成的結塊問題。 The structure of Huangqi polysaccharide crystal particles is further added with mannose as a structural matching component. Through the structural design, the problem of agglomeration caused by the characteristics of both Huangqi and mannose are extremely hygroscopic.

其中甘露糖經實驗證實,甘露糖可以抑制葡萄糖在罹癌小鼠體內細胞內的代謝,也可以使其降低丙酮酸的生成。 Among them, mannose has been experimentally confirmed that mannose can inhibit the metabolism of glucose in the cells of cancer-bearing mice, and can also reduce the production of pyruvate.

本新型提供一種一黃耆多醣晶體顆粒結構,包含:一黃耆多醣顆粒;一甘露醣顆粒;及一水鏈結構,一端鏈接該黃耆多醣顆粒,一端鏈接該甘露醣顆粒。 The invention provides a yellow agaric polysaccharide crystal particle structure, comprising: a yellow agaric polysaccharide particle; a mannose particle; and a water chain structure, one end of the yellow agaric polysaccharide particle is linked to one end and the mannose particle.

在本新型之一實施例中,該水鏈結構係由水分子鏈結形成。 In one embodiment of the present invention, the water chain structure is formed by water molecule links.

在本新型之一實施例中,該水鏈結構為圓球或類圓形狀。 In one embodiment of the present invention, the water chain structure has a spherical shape or a round shape.

在本新型之一實施例中,該黃耆多醣顆粒和該甘露糖顆粒藉由該水鏈結構形成啞鈴型結構。 In an embodiment of the present invention, the Huangqi polysaccharide particles and the mannose particles form a dumbbell-shaped structure by the water chain structure.

在本新型之一實施例中,該黃耆多醣顆粒和該甘露糖顆粒系1:2結合。 In one embodiment of the present invention, the Huangqi polysaccharide particles and the mannose particles are combined 1:2.

在本新型之一實施例中,該黃耆多醣顆粒和該甘露糖顆粒系1:3結合。 In one embodiment of the present invention, the Huangqi polysaccharide particles and the mannose particles are combined 1:3.

在本新型之一實施例中,該水鏈結構會降低製造過程中黏著成塊狀的狀況。 In one embodiment of the present invention, the water chain structure will reduce the stickiness during the manufacturing process.

在本新型之一實施例中,該黃耆多醣晶體顆粒結構具有干擾並降低癌細胞增生作用。 In one embodiment of the present invention, the crystal structure of Astragalus polysaccharides has the effect of interfering with and reducing the proliferation of cancer cells.

在本新型之一實施例中,該黃耆多醣晶體顆粒結構具有抑制癌細胞對於葡萄糖的異常代謝。 In one embodiment of the present invention, the Astragalus polysaccharide crystal particle structure has the ability to inhibit abnormal metabolism of glucose by cancer cells.

在本新型之一實施例中,該黃耆多醣晶體顆粒結構具有提升食用後在體內的溶解力與吸收率。 In one embodiment of the present invention, the agaric polysaccharide crystal particle structure has improved solubility and absorption rate in the body after consumption.

在本新型之一實施例中,該黃耆多醣晶體顆粒結構可製造為粉劑包、飲品、膠囊或錠劑之形式,以供使用者依需求選用。 In one embodiment of the present invention, the crystal structure of the polysaccharide crystals of Astragalus can be manufactured in the form of powder packets, drinks, capsules or lozenges for users to choose according to their needs.

10:甘露醣顆粒 10: mannose granules

20:水鏈結構 20: Water chain structure

30:黃耆多醣顆粒 30: Huangqi polysaccharide particles

第一圖係為黃耆多醣晶體顆粒結構單體型式。 The first picture is the monomer type of Huangqi polysaccharide crystal particle structure.

第二圖係為黃耆多醣晶體顆粒結構另一單體型式。 The second picture is another monomer type of the Huangqi polysaccharide crystal particle structure.

第三圖係為黃耆多醣晶體顆粒結構均勻分散於溶液中。 The third picture shows that the crystal structure of the polysaccharide crystals of Astragalus mongholicus was evenly dispersed in the solution.

為令本創作所運用之技術內容、創作目的及其達成之功效有更完整且清楚的揭露,茲於下詳細說明之,並請一併參閱所揭之圖式及圖號。 In order to provide a more complete and clear disclosure of the technical content used in this creation, the purpose of the creation and the effect achieved, please refer to the detailed description below, and please refer to the drawings and figures.

實施例1:黃耆多醣萃取物之製備方法Example 1: Preparation method of polysaccharide extract of Astragalus membranaceus

黃耆本身為一種植物藥藥材,植物性藥材功效特性與化學藥物相差甚鉅。化學藥物都是利用一連串化學反應式去產生「單一化合物」,進而製作成藥品。但是植物性藥材則不一樣,植物性藥材本身含有複雜,可能多達上百種的功效成分同時存在植株內,所以必須使用專門性,特殊專為此種藥材開發的分離與純化製程。 Huang Qi itself is a botanical medicinal material, and the efficacy characteristics of botanical medicinal materials are very different from chemical drugs. Chemical drugs use a series of chemical reactions to produce "single compounds", which are then made into medicines. But plant-based medicinal materials are different. Plant-based medicinal materials themselves are complex, and as many as hundreds of functional ingredients may exist in the plant at the same time, so specialization must be used, especially for the separation and purification process specially developed for such medicinal materials.

本黃耆原料分離純化製程,係利用黃耆的主要活性功能成分,多醣體、胺基酸、異黃酮與皂苷等功效成分,在不同的醇水比例下,產生的不同的親疏水特性,使其達到對黃耆多醣體、胺基酸、異黃酮、皂苷成分的分離,達到專一純化的目的,進而再取得黃耆多醣顆粒。 The process of separation and purification of raw materials of Huangqi uses the main active functional components of Huangqi, polysaccharides, amino acids, isoflavones, saponins and other functional components. It achieves the separation of the components of Astragalus polysaccharides, amino acids, isoflavones, and saponins, and achieves the purpose of specific purification, and then obtains the polysaccharides of Astragalus polysaccharides.

實施例2:黃耆多醣晶體顆粒結構之製備方法與結構Example 2: Preparation method and structure of Huangqi polysaccharide crystal particle structure

黃耆萃取物為一潮濕粉體狀態,流動性極差,無法進行產品下料包裝的製程。且黃耆萃取物含高濃度的多醣體,但是因為多醣體具有易吸收濕氣,與高黏性高膠化的特性,經過一段時間,會黏著成一大塊不水溶的硬塊。 The extract of Huangqi is in a moist powder state, and its fluidity is very poor, so it is impossible to carry out the process of product packaging. Moreover, the extract of Astragalus membranaceus contains a high concentration of polysaccharides, but because the polysaccharides have the characteristics of easily absorbing moisture, high viscosity and high gelation, after a period of time, they will stick to a large water-insoluble hard block.

因此將萃取得到的黃耆多醣顆粒進一步透過特殊多晶體造粒製程,製造本新型創作黃耆多醣晶體顆粒結構,使黃耆多醣顆粒(30)和甘露糖顆粒(10)藉由水鏈結構(20)形成如第一圖之黃耆多醣晶體顆粒結構,黃耆多醣晶體顆粒結構單體結構可能為啞鈴型結構,亦有可能由於水鏈結構(20)本身在製程中形成多種形態,因此,會形成有如第二圖之黃耆多醣晶體顆粒結 構另一單體型式,可以一次與2個黃耆多醣顆粒(30)和2個甘露糖顆粒(10)。 Therefore, the extracted Huangqi polysaccharide particles are further passed through a special multi-crystal granulation process to manufacture the new creation of Huangqi polysaccharide crystal particle structure, so that the Huangqi polysaccharide particles (30) and mannose particles (10) through the water chain structure ( 20) Form the crystal structure of Huangqi polysaccharide crystal particles as shown in the first picture. The monomer structure of Huangqi polysaccharide crystal particle structure may be a dumbbell-shaped structure, or it may be due to the formation of various forms during the manufacturing process of the water chain structure (20). It will form the knot polysaccharide crystal particles as shown in the second picture To construct another monomer type, it can be combined with 2 Huangqi polysaccharide particles (30) and 2 mannose particles (10) at a time.

本產品製作過程中,特採用噴霧小顆粒造粒製程,除了硬體上,採用混合、造粒、乾燥或冷卻一次完成,避免外部污染的方式,同時亦利用特定的風速,粉量與極低的水霧比例,製成均勻度高的小顆粒,除了避免產品隨著時間快速膠化,形成團塊。 In the production process of this product, the spray granulation process is specially used. In addition to the hardware, mixing, granulation, drying or cooling are completed at one time to avoid external pollution. At the same time, it uses a specific wind speed, powder volume and extremely low The proportion of water mist is made into small particles with high uniformity, in addition to avoiding the product quickly gelling and forming clumps over time.

特殊多晶體造粒製程,解決黃耆多醣顆粒(30)和甘露糖顆粒(10)均為極易吸濕的特性造成的結塊問題,透過水鏈結構(20)鏈接可以讓兩者之間擁有一定的距離並且,在容易之中造成空隙,使黃耆多醣顆粒(30)和甘露糖顆粒(10)快速膠化,形成團塊。 Special multi-crystal granulation process to solve the problem of agglomeration caused by the characteristics of Huangqi polysaccharide particles (30) and mannose particles (10), which are extremely hygroscopic. The water chain structure (20) can be used to link the two. It has a certain distance and creates gaps in the easy, so that the Huangqi polysaccharide particles (30) and mannose particles (10) quickly gelatinize to form clumps.

同時增加產品的身體吸收率,提升產品功效黃耆多醣顆粒(30)和甘露糖顆粒(10)和水鏈結構(20)會均勻的分散於溶液中如第三圖,後續在進行造粒程序步驟,將水鏈結構(20)烘乾去除,烘乾後即可成為均勻分布的黃耆多醣顆粒(30)和甘露糖顆粒(10)產品。雖然水鏈結構(20)最後被去除,但是因為黃耆多醣顆粒很黏稠,所以顆粒不會崩散,主要也是因黃耆多醣顆粒(30)本身的黏性會黏著甘露糖顆粒(10)。 At the same time increase the body absorption rate of the product and enhance the product's efficacy. The Huangqi polysaccharide particles (30) and mannose particles (10) and the water chain structure (20) will be evenly dispersed in the solution as shown in the third figure, followed by the granulation process In the step, the water chain structure (20) is dried and removed, and after drying, it can become a homogeneously distributed product of polysaccharide particles (30) and mannose particles (10). Although the water chain structure (20) was finally removed, the particles of Huangqi polysaccharides were very viscous, so the particles did not fall apart, mainly because the viscosity of the Huangqi polysaccharide particles (30) adhered to the mannose particles (10).

實施例3:黃耆多醣晶體顆粒結構之臨床效果Example 3: Clinical effect of Huangqi polysaccharide crystal particle structure

黃耆多醣顆粒(30)和甘露糖顆粒(10)和水鏈結構(20)會均勻的分散於溶液中如第三圖,均勻分散的黃耆多醣晶體顆粒結構小顆粒更可以比大顆粒有更大的體表面積,提升食用後在體內的溶解力與吸收率,提升產品功效。 Huangqi polysaccharide particles (30) and mannose particles (10) and water chain structure (20) will be uniformly dispersed in the solution. As shown in the third figure, the uniformly dispersed Huangqi polysaccharide crystal particle structure small particles can be more than large particles Larger body surface area enhances the dissolving power and absorption rate in the body after consumption, and enhances the efficacy of the product.

在癌症慢慢生成的過程中,因為壓力或是緊繃的情緒造成身體壓力賀爾蒙大量分泌(腎上腺素),造成血管收縮,進而讓身體處於低體溫、高血糖的缺氧狀態,此時細胞會傾向進行無氧呼吸以在短時間內獲取大量的能量去度過困難,但是此能量反應路徑,會留下大量的丙酮酸,進而成為乳酸,會促進腫瘤生長。根據研究,腫瘤細胞會捨棄一般正常的粒腺體有氧呼吸產能的路徑(丙酮酸會被代謝掉,沒有剩下),而改用細胞的無氧呼吸,目的就是將丙酮酸留下,以供其快速增生使用。 In the process of slowly developing cancer, due to stress or tight emotions, the body's stress hormones are secreted in large amounts (adrenaline), causing blood vessels to contract, which in turn places the body in an hypoxic state with low body temperature and high blood sugar. Cells will tend to anaerobic breathing to obtain a large amount of energy in a short time to overcome difficulties, but this energy reaction path will leave a lot of pyruvate, which in turn becomes lactic acid, which will promote tumor growth. According to research, tumor cells will abandon the path of normal aerobic respiration capacity of mitochondria (pyruvate will be metabolized, there is no remaining), and the use of anaerobic respiration of cells, the purpose is to leave pyruvate to For its rapid proliferation.

黃耆多醣晶體顆粒結構產品其特殊組合的意義在於,綜觀癌症整個生成與養成過程,利用不同的成分的功效特性,一個逆轉身體狀況(有氧/缺氧狀態),一個抑制癌細胞對於葡萄糖的異常代謝。透過分別轉化癌細胞生成與增生過程中不同的重要變異點,同時輔以高純度好吸收的小顆粒劑型,以達到干擾並降低癌細胞增生的目的。 The significance of the special combination of Huangqi polysaccharide crystal particle structure products is that, looking at the entire process of cancer generation and growth, using the efficacy characteristics of different ingredients, one reverses the physical condition (aerobic/hypoxic state), and one inhibits the cancer cells' glucose for glucose. Abnormal metabolism. By transforming different important mutation points in the process of cancer cell generation and hyperplasia separately, supplemented by small particles of high purity and good absorption, in order to achieve the purpose of interfering with and reducing the proliferation of cancer cells.

10:甘露醣顆粒 10: mannose granules

20:水鏈結構 20: Water chain structure

30:黃耆多醣顆粒 30: Huangqi polysaccharide particles

Claims (10)

一種提升溶解力與吸收率黃耆多醣晶體顆粒結構,包含: A crystal structure of Astragalus polysaccharide crystals for improving dissolution and absorption rate, including: 一黃耆多醣顆粒; One yellow agaric polysaccharide particles; 一甘露醣顆粒;及 1 mannose granule; and 一水鏈結構,一端鏈接該黃耆多醣顆粒,一端鏈接該甘露醣顆粒。 A water chain structure, one end links the yellow agaric polysaccharide particles and one end links the mannose particles. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該水鏈結構係由水分子鏈結形成。 The crystal structure of the polysaccharide crystal of Astragalus polysaccharides as described in item 1 of the patent application scope, wherein the water chain structure is formed by water molecule chains. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該水鏈結構為柱狀或圓球狀。 The crystal structure of the polysaccharide crystal of Astragalus polysaccharides as described in item 1 of the patent application, wherein the water chain structure is columnar or spherical. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多醣顆粒和該甘露糖顆粒藉由該水鏈結構形成啞鈴型結構。 The yellow agaric polysaccharide crystal particle structure as described in item 1 of the patent application scope, wherein the yellow agar polysaccharide particles and the mannose particles form a dumbbell-shaped structure by the water chain structure. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多醣顆粒和該甘露糖顆粒系1:2結合。 The crystal structure of Huangqi polysaccharide crystals as described in item 1 of the patent application scope, wherein the Huangqi polysaccharide particles and the mannose particles are combined in a 1:2 ratio. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多醣顆粒和該甘露糖顆粒系1:3結合。 The crystal structure of Huangqi polysaccharide as described in item 1 of the patent application scope, wherein the Huangqi polysaccharide particles and the mannose particles are combined in a 1:3 ratio. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該水鏈結構會降低製造過程中黏著成塊狀的狀況。 As described in the first paragraph of the patent application, the polysaccharide crystal particle structure of Astragalus membranaceus, wherein the water chain structure will reduce the stickiness of the polysaccharide during the manufacturing process. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多晶體顆粒結構具有干擾並降低癌細胞增生作用。 The Huangqi polysaccharide crystal particle structure as described in item 1 of the patent application scope, wherein the Huangqi polycrystalline particle structure has interference and reduces the proliferation of cancer cells. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多晶體顆粒結構具有抑制癌細胞對於葡萄糖的異常代謝。 The Huangqi polysaccharide crystal particle structure as described in Item 1 of the patent application range, wherein the Huangqi polycrystalline particle structure has the ability to inhibit the abnormal metabolism of glucose by cancer cells. 如申請專利範圍第1項所述之黃耆多醣晶體顆粒結構,其中該黃耆多晶體顆粒結構具有提升食用後在體內的溶解力與吸收率。 The Huangqi polysaccharide crystal particle structure as described in Item 1 of the patent application scope, wherein the Huangqi polycrystalline particle structure has improved dissolution power and absorption rate in the body after consumption.
TW109202035U 2020-02-24 2020-02-24 Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate TWM597140U (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW109202035U TWM597140U (en) 2020-02-24 2020-02-24 Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate
JP2020001395U JP3228581U (en) 2020-02-24 2020-04-17 Granules containing Ogi polysaccharide that improves dissolving power and absorption rate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109202035U TWM597140U (en) 2020-02-24 2020-02-24 Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate

Publications (1)

Publication Number Publication Date
TWM597140U true TWM597140U (en) 2020-06-21

Family

ID=72177684

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109202035U TWM597140U (en) 2020-02-24 2020-02-24 Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate

Country Status (2)

Country Link
JP (1) JP3228581U (en)
TW (1) TWM597140U (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202206090A (en) * 2020-03-17 2022-02-16 懷特生技新藥股份有限公司 Astragalus pharmaceutical composition enhances the use of cancer treatment

Also Published As

Publication number Publication date
JP3228581U (en) 2020-11-05

Similar Documents

Publication Publication Date Title
CN100563697C (en) Rhodiola rosea hippophae rhamnoides patch and preparation method thereof
WO2020113811A1 (en) Biopolymer nanosphere containing nicotinamide mononucleotide, preparation method therefor and use thereof
CN103961469A (en) Traditional Chinese medicinal composition and application thereof, healthy product and preparation method thereof
CN106562438A (en) Immunity enhancement composition and preparation method thereof
CN103610752A (en) Functional food with hypoglycemic effect and preparation method thereof
TWM597140U (en) Astmgali radix polysaccharide crystal grain structure with enhanced dissolving capability and absorption rate
CN101007071A (en) Traditional Chinese medicine for treating acute and chronic gastroenteritis and bacterial dysentery and its processing technology
CN114916604A (en) Gel candy with health care function
Guo et al. Natural edible materials made of protein-functionalized aerogel particles for postprandial hyperglycemia management
CN112790269A (en) Composite selenoprotein peptide tablet candy and preparation method thereof
CN107897875A (en) It is a kind of to be used to improve Se-enriched yeast zinc metal sheet of sperm quality and vigor and preparation method thereof
CN111870627A (en) Sobering-up preparation and its preparing method and use
Dai et al. Preparation, Biological Activities, and Application of Plant Polysaccharide Iron Complexes: A Review
CN110881555A (en) Dispersible candy tablet with dual-effect of lowering blood pressure
CN113633657B (en) Pharmaceutical composition for improving body anti-fatigue, hypoxia-resistant, heat-resistant and cold-resistant capacities and application thereof
CN109010514A (en) Composition, health care product and the preparation method of altitude sickness prevention
CN108323762B (en) Selenium-rich composition and preparation, preparation method and application thereof
CN101264129A (en) Sugar-free heart-supplementing dracocephali moldavica granula
CN104971051A (en) Cetilistat tablet and preparation method
CN1303979C (en) Preparation of snake gallbladder and tangerine peel dispersed tablets
CN102225082A (en) Medicament for preventing and treating diabetes and complications thereof and preparation method thereof
CN108065395A (en) A kind of brain tonic and intelligence development body-building health food and preparation method thereof
CN110339229B (en) Viscosity-reducing and blood-clearing composition and application thereof
WO2024040630A1 (en) Composition for controlling blood glucose, preparation method therefor, and use of same in reducing gi value of foods
CN1709151A (en) Method for preparing micron pearl particle and capsule fo assisting sleep, tonifying intestine and supplying calcium